Merck to Acquire Investigational B-Cell Depletion Therapy, CN201, from[...]
Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results
08/09/2024 | Press release | Distributed by Public on 08/09/2024 04:43
Please select the service you want to use:
Smartlinks | Embecta Corporation | News | Health | Company News | Securities Issuers | Medical Supplies and Equipment Companies | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact